nodes	percent_of_prediction	percent_of_DWPC	metapath
Aztreonam—Purpura—Triamcinolone—ankylosing spondylitis	0.00745	0.00745	CcSEcCtD
Aztreonam—Abdominal distension—Prednisolone—ankylosing spondylitis	0.0068	0.0068	CcSEcCtD
Aztreonam—Sweating increased—Prednisolone—ankylosing spondylitis	0.00658	0.00658	CcSEcCtD
Aztreonam—Thrombophlebitis—Prednisone—ankylosing spondylitis	0.00656	0.00656	CcSEcCtD
Aztreonam—Vaginal inflammation—Methotrexate—ankylosing spondylitis	0.00654	0.00654	CcSEcCtD
Aztreonam—Vascular purpura—Prednisone—ankylosing spondylitis	0.00635	0.00635	CcSEcCtD
Aztreonam—Alanine aminotransferase increased—Methylprednisolone—ankylosing spondylitis	0.00632	0.00632	CcSEcCtD
Aztreonam—Abdominal distension—Triamcinolone—ankylosing spondylitis	0.00625	0.00625	CcSEcCtD
Aztreonam—Abdominal distension—Methylprednisolone—ankylosing spondylitis	0.00624	0.00624	CcSEcCtD
Aztreonam—Vaginal infection—Methotrexate—ankylosing spondylitis	0.00617	0.00617	CcSEcCtD
Aztreonam—Bronchospasm—Methylprednisolone—ankylosing spondylitis	0.00609	0.00609	CcSEcCtD
Aztreonam—Sweating increased—Triamcinolone—ankylosing spondylitis	0.00605	0.00605	CcSEcCtD
Aztreonam—Sweating increased—Methylprednisolone—ankylosing spondylitis	0.00603	0.00603	CcSEcCtD
Aztreonam—Mouth ulceration—Methotrexate—ankylosing spondylitis	0.00591	0.00591	CcSEcCtD
Aztreonam—Purpura—Prednisone—ankylosing spondylitis	0.00589	0.00589	CcSEcCtD
Aztreonam—Gastrointestinal haemorrhage—Prednisone—ankylosing spondylitis	0.00568	0.00568	CcSEcCtD
Aztreonam—Sweating increased—Dexamethasone—ankylosing spondylitis	0.00549	0.00549	CcSEcCtD
Aztreonam—Sweating increased—Betamethasone—ankylosing spondylitis	0.00549	0.00549	CcSEcCtD
Aztreonam—Thrombophlebitis—Methotrexate—ankylosing spondylitis	0.00548	0.00548	CcSEcCtD
Aztreonam—Haemoglobin—Prednisolone—ankylosing spondylitis	0.00543	0.00543	CcSEcCtD
Aztreonam—Haemorrhage—Prednisolone—ankylosing spondylitis	0.0054	0.0054	CcSEcCtD
Aztreonam—Dermatitis exfoliative—Methotrexate—ankylosing spondylitis	0.00503	0.00503	CcSEcCtD
Aztreonam—Alanine aminotransferase increased—Prednisone—ankylosing spondylitis	0.00501	0.00501	CcSEcCtD
Aztreonam—Haemoglobin—Triamcinolone—ankylosing spondylitis	0.00499	0.00499	CcSEcCtD
Aztreonam—Haemoglobin—Methylprednisolone—ankylosing spondylitis	0.00498	0.00498	CcSEcCtD
Aztreonam—Haemorrhage—Triamcinolone—ankylosing spondylitis	0.00497	0.00497	CcSEcCtD
Aztreonam—Haemorrhage—Methylprednisolone—ankylosing spondylitis	0.00496	0.00496	CcSEcCtD
Aztreonam—Abdominal distension—Prednisone—ankylosing spondylitis	0.00494	0.00494	CcSEcCtD
Aztreonam—Sweating increased—Prednisone—ankylosing spondylitis	0.00478	0.00478	CcSEcCtD
Aztreonam—Erythema—Prednisolone—ankylosing spondylitis	0.0047	0.0047	CcSEcCtD
Aztreonam—Neutropenia—Prednisone—ankylosing spondylitis	0.00459	0.00459	CcSEcCtD
Aztreonam—Haemoglobin—Dexamethasone—ankylosing spondylitis	0.00453	0.00453	CcSEcCtD
Aztreonam—Haemoglobin—Betamethasone—ankylosing spondylitis	0.00453	0.00453	CcSEcCtD
Aztreonam—Haemorrhage—Betamethasone—ankylosing spondylitis	0.00451	0.00451	CcSEcCtD
Aztreonam—Haemorrhage—Dexamethasone—ankylosing spondylitis	0.00451	0.00451	CcSEcCtD
Aztreonam—Ill-defined disorder—Prednisolone—ankylosing spondylitis	0.00436	0.00436	CcSEcCtD
Aztreonam—Erythema—Triamcinolone—ankylosing spondylitis	0.00433	0.00433	CcSEcCtD
Aztreonam—Erythema—Methylprednisolone—ankylosing spondylitis	0.00432	0.00432	CcSEcCtD
Aztreonam—Angioedema—Prednisolone—ankylosing spondylitis	0.0043	0.0043	CcSEcCtD
Aztreonam—Toxic epidermal necrolysis—Methotrexate—ankylosing spondylitis	0.00427	0.00427	CcSEcCtD
Aztreonam—Malaise—Prednisolone—ankylosing spondylitis	0.00424	0.00424	CcSEcCtD
Aztreonam—Dysgeusia—Triamcinolone—ankylosing spondylitis	0.00424	0.00424	CcSEcCtD
Aztreonam—Vertigo—Prednisolone—ankylosing spondylitis	0.00423	0.00423	CcSEcCtD
Aztreonam—Convulsion—Prednisolone—ankylosing spondylitis	0.00408	0.00408	CcSEcCtD
Aztreonam—Eosinophilia—Methotrexate—ankylosing spondylitis	0.00406	0.00406	CcSEcCtD
Aztreonam—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.00401	0.00401	CcSEcCtD
Aztreonam—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.004	0.004	CcSEcCtD
Aztreonam—Discomfort—Prednisolone—ankylosing spondylitis	0.00396	0.00396	CcSEcCtD
Aztreonam—Angioedema—Triamcinolone—ankylosing spondylitis	0.00395	0.00395	CcSEcCtD
Aztreonam—Haemoglobin—Prednisone—ankylosing spondylitis	0.00395	0.00395	CcSEcCtD
Aztreonam—Angioedema—Methylprednisolone—ankylosing spondylitis	0.00394	0.00394	CcSEcCtD
Aztreonam—Haemorrhage—Prednisone—ankylosing spondylitis	0.00393	0.00393	CcSEcCtD
Aztreonam—Erythema—Dexamethasone—ankylosing spondylitis	0.00393	0.00393	CcSEcCtD
Aztreonam—Erythema—Betamethasone—ankylosing spondylitis	0.00393	0.00393	CcSEcCtD
Aztreonam—Malaise—Triamcinolone—ankylosing spondylitis	0.0039	0.0039	CcSEcCtD
Aztreonam—Pancytopenia—Methotrexate—ankylosing spondylitis	0.00389	0.00389	CcSEcCtD
Aztreonam—Malaise—Methylprednisolone—ankylosing spondylitis	0.00389	0.00389	CcSEcCtD
Aztreonam—Vertigo—Triamcinolone—ankylosing spondylitis	0.00389	0.00389	CcSEcCtD
Aztreonam—Vertigo—Methylprednisolone—ankylosing spondylitis	0.00388	0.00388	CcSEcCtD
Aztreonam—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.00384	0.00384	CcSEcCtD
Aztreonam—Neutropenia—Methotrexate—ankylosing spondylitis	0.00383	0.00383	CcSEcCtD
Aztreonam—Cough—Triamcinolone—ankylosing spondylitis	0.00377	0.00377	CcSEcCtD
Aztreonam—Convulsion—Triamcinolone—ankylosing spondylitis	0.00375	0.00375	CcSEcCtD
Aztreonam—Convulsion—Methylprednisolone—ankylosing spondylitis	0.00374	0.00374	CcSEcCtD
Aztreonam—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00371	0.00371	CcSEcCtD
Aztreonam—Myalgia—Triamcinolone—ankylosing spondylitis	0.00368	0.00368	CcSEcCtD
Aztreonam—Myalgia—Methylprednisolone—ankylosing spondylitis	0.00367	0.00367	CcSEcCtD
Aztreonam—Flushing—Prednisone—ankylosing spondylitis	0.00364	0.00364	CcSEcCtD
Aztreonam—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.00364	0.00364	CcSEcCtD
Aztreonam—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.00364	0.00364	CcSEcCtD
Aztreonam—Discomfort—Triamcinolone—ankylosing spondylitis	0.00364	0.00364	CcSEcCtD
Aztreonam—Discomfort—Methylprednisolone—ankylosing spondylitis	0.00363	0.00363	CcSEcCtD
Aztreonam—Angioedema—Dexamethasone—ankylosing spondylitis	0.00359	0.00359	CcSEcCtD
Aztreonam—Angioedema—Betamethasone—ankylosing spondylitis	0.00359	0.00359	CcSEcCtD
Aztreonam—Stomatitis—Methotrexate—ankylosing spondylitis	0.00356	0.00356	CcSEcCtD
Aztreonam—Confusional state—Methylprednisolone—ankylosing spondylitis	0.00355	0.00355	CcSEcCtD
Aztreonam—Malaise—Betamethasone—ankylosing spondylitis	0.00354	0.00354	CcSEcCtD
Aztreonam—Malaise—Dexamethasone—ankylosing spondylitis	0.00354	0.00354	CcSEcCtD
Aztreonam—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.00353	0.00353	CcSEcCtD
Aztreonam—Vertigo—Dexamethasone—ankylosing spondylitis	0.00353	0.00353	CcSEcCtD
Aztreonam—Vertigo—Betamethasone—ankylosing spondylitis	0.00353	0.00353	CcSEcCtD
Aztreonam—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.00352	0.00352	CcSEcCtD
Aztreonam—Insomnia—Prednisolone—ankylosing spondylitis	0.00347	0.00347	CcSEcCtD
Aztreonam—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00345	0.00345	CcSEcCtD
Aztreonam—Erythema—Prednisone—ankylosing spondylitis	0.00342	0.00342	CcSEcCtD
Aztreonam—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00341	0.00341	CcSEcCtD
Aztreonam—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00341	0.00341	CcSEcCtD
Aztreonam—Convulsion—Dexamethasone—ankylosing spondylitis	0.0034	0.0034	CcSEcCtD
Aztreonam—Convulsion—Betamethasone—ankylosing spondylitis	0.0034	0.0034	CcSEcCtD
Aztreonam—Myalgia—Betamethasone—ankylosing spondylitis	0.00334	0.00334	CcSEcCtD
Aztreonam—Myalgia—Dexamethasone—ankylosing spondylitis	0.00334	0.00334	CcSEcCtD
Aztreonam—Discomfort—Betamethasone—ankylosing spondylitis	0.0033	0.0033	CcSEcCtD
Aztreonam—Discomfort—Dexamethasone—ankylosing spondylitis	0.0033	0.0033	CcSEcCtD
Aztreonam—Haemoglobin—Methotrexate—ankylosing spondylitis	0.0033	0.0033	CcSEcCtD
Aztreonam—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00329	0.00329	CcSEcCtD
Aztreonam—Pain—Prednisolone—ankylosing spondylitis	0.00328	0.00328	CcSEcCtD
Aztreonam—Hepatitis—Methotrexate—ankylosing spondylitis	0.00328	0.00328	CcSEcCtD
Aztreonam—Haemorrhage—Methotrexate—ankylosing spondylitis	0.00328	0.00328	CcSEcCtD
Aztreonam—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00322	0.00322	CcSEcCtD
Aztreonam—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00321	0.00321	CcSEcCtD
Aztreonam—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.0032	0.0032	CcSEcCtD
Aztreonam—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.0032	0.0032	CcSEcCtD
Aztreonam—Insomnia—Triamcinolone—ankylosing spondylitis	0.00319	0.00319	CcSEcCtD
Aztreonam—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00319	0.00319	CcSEcCtD
Aztreonam—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.00317	0.00317	CcSEcCtD
Aztreonam—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00317	0.00317	CcSEcCtD
Aztreonam—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00316	0.00316	CcSEcCtD
Aztreonam—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00316	0.00316	CcSEcCtD
Aztreonam—Anaemia—Prednisone—ankylosing spondylitis	0.00316	0.00316	CcSEcCtD
Aztreonam—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00315	0.00315	CcSEcCtD
Aztreonam—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.00314	0.00314	CcSEcCtD
Aztreonam—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.00314	0.00314	CcSEcCtD
Aztreonam—Angioedema—Prednisone—ankylosing spondylitis	0.00312	0.00312	CcSEcCtD
Aztreonam—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.0031	0.0031	CcSEcCtD
Aztreonam—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.0031	0.0031	CcSEcCtD
Aztreonam—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.0031	0.0031	CcSEcCtD
Aztreonam—Malaise—Prednisone—ankylosing spondylitis	0.00308	0.00308	CcSEcCtD
Aztreonam—Vertigo—Prednisone—ankylosing spondylitis	0.00307	0.00307	CcSEcCtD
Aztreonam—Tinnitus—Methotrexate—ankylosing spondylitis	0.00306	0.00306	CcSEcCtD
Aztreonam—Urticaria—Prednisolone—ankylosing spondylitis	0.00305	0.00305	CcSEcCtD
Aztreonam—Pain—Triamcinolone—ankylosing spondylitis	0.00302	0.00302	CcSEcCtD
Aztreonam—Hypotension—Betamethasone—ankylosing spondylitis	0.00299	0.00299	CcSEcCtD
Aztreonam—Hypotension—Dexamethasone—ankylosing spondylitis	0.00299	0.00299	CcSEcCtD
Aztreonam—Convulsion—Prednisone—ankylosing spondylitis	0.00296	0.00296	CcSEcCtD
Aztreonam—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00292	0.00292	CcSEcCtD
Aztreonam—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00292	0.00292	CcSEcCtD
Aztreonam—Myalgia—Prednisone—ankylosing spondylitis	0.00291	0.00291	CcSEcCtD
Aztreonam—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00291	0.00291	CcSEcCtD
Aztreonam—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.0029	0.0029	CcSEcCtD
Aztreonam—Insomnia—Betamethasone—ankylosing spondylitis	0.0029	0.0029	CcSEcCtD
Aztreonam—Insomnia—Dexamethasone—ankylosing spondylitis	0.0029	0.0029	CcSEcCtD
Aztreonam—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00288	0.00288	CcSEcCtD
Aztreonam—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00288	0.00288	CcSEcCtD
Aztreonam—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00288	0.00288	CcSEcCtD
Aztreonam—Discomfort—Prednisone—ankylosing spondylitis	0.00288	0.00288	CcSEcCtD
Aztreonam—Erythema—Methotrexate—ankylosing spondylitis	0.00286	0.00286	CcSEcCtD
Aztreonam—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00283	0.00283	CcSEcCtD
Aztreonam—Urticaria—Triamcinolone—ankylosing spondylitis	0.0028	0.0028	CcSEcCtD
Aztreonam—Urticaria—Methylprednisolone—ankylosing spondylitis	0.0028	0.0028	CcSEcCtD
Aztreonam—Dysgeusia—Methotrexate—ankylosing spondylitis	0.0028	0.0028	CcSEcCtD
Aztreonam—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.00279	0.00279	CcSEcCtD
Aztreonam—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.00279	0.00279	CcSEcCtD
Aztreonam—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00278	0.00278	CcSEcCtD
Aztreonam—Pain—Dexamethasone—ankylosing spondylitis	0.00274	0.00274	CcSEcCtD
Aztreonam—Pain—Betamethasone—ankylosing spondylitis	0.00274	0.00274	CcSEcCtD
Aztreonam—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.0027	0.0027	CcSEcCtD
Aztreonam—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.00265	0.00265	CcSEcCtD
Aztreonam—Anaemia—Methotrexate—ankylosing spondylitis	0.00264	0.00264	CcSEcCtD
Aztreonam—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00264	0.00264	CcSEcCtD
Aztreonam—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00264	0.00264	CcSEcCtD
Aztreonam—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00262	0.00262	CcSEcCtD
Aztreonam—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00262	0.00262	CcSEcCtD
Aztreonam—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.0026	0.0026	CcSEcCtD
Aztreonam—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.0026	0.0026	CcSEcCtD
Aztreonam—Malaise—Methotrexate—ankylosing spondylitis	0.00258	0.00258	CcSEcCtD
Aztreonam—Vertigo—Methotrexate—ankylosing spondylitis	0.00257	0.00257	CcSEcCtD
Aztreonam—Urticaria—Betamethasone—ankylosing spondylitis	0.00254	0.00254	CcSEcCtD
Aztreonam—Urticaria—Dexamethasone—ankylosing spondylitis	0.00254	0.00254	CcSEcCtD
Aztreonam—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.00254	0.00254	CcSEcCtD
Aztreonam—Dizziness—Prednisolone—ankylosing spondylitis	0.00254	0.00254	CcSEcCtD
Aztreonam—Asthenia—Triamcinolone—ankylosing spondylitis	0.00253	0.00253	CcSEcCtD
Aztreonam—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00253	0.00253	CcSEcCtD
Aztreonam—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00253	0.00253	CcSEcCtD
Aztreonam—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.00253	0.00253	CcSEcCtD
Aztreonam—Body temperature increased—Betamethasone—ankylosing spondylitis	0.00253	0.00253	CcSEcCtD
Aztreonam—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00253	0.00253	CcSEcCtD
Aztreonam—Insomnia—Prednisone—ankylosing spondylitis	0.00252	0.00252	CcSEcCtD
Aztreonam—Paraesthesia—Prednisone—ankylosing spondylitis	0.00251	0.00251	CcSEcCtD
Aztreonam—Pruritus—Triamcinolone—ankylosing spondylitis	0.0025	0.0025	CcSEcCtD
Aztreonam—Cough—Methotrexate—ankylosing spondylitis	0.00249	0.00249	CcSEcCtD
Aztreonam—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00249	0.00249	CcSEcCtD
Aztreonam—Convulsion—Methotrexate—ankylosing spondylitis	0.00248	0.00248	CcSEcCtD
Aztreonam—Chest pain—Methotrexate—ankylosing spondylitis	0.00243	0.00243	CcSEcCtD
Aztreonam—Myalgia—Methotrexate—ankylosing spondylitis	0.00243	0.00243	CcSEcCtD
Aztreonam—Rash—Prednisolone—ankylosing spondylitis	0.00242	0.00242	CcSEcCtD
Aztreonam—Dermatitis—Prednisolone—ankylosing spondylitis	0.00242	0.00242	CcSEcCtD
Aztreonam—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00241	0.00241	CcSEcCtD
Aztreonam—Headache—Prednisolone—ankylosing spondylitis	0.00241	0.00241	CcSEcCtD
Aztreonam—Discomfort—Methotrexate—ankylosing spondylitis	0.0024	0.0024	CcSEcCtD
Aztreonam—Confusional state—Methotrexate—ankylosing spondylitis	0.00235	0.00235	CcSEcCtD
Aztreonam—Dizziness—Triamcinolone—ankylosing spondylitis	0.00233	0.00233	CcSEcCtD
Aztreonam—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.00233	0.00233	CcSEcCtD
Aztreonam—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00233	0.00233	CcSEcCtD
Aztreonam—Feeling abnormal—Prednisone—ankylosing spondylitis	0.0023	0.0023	CcSEcCtD
Aztreonam—Asthenia—Betamethasone—ankylosing spondylitis	0.0023	0.0023	CcSEcCtD
Aztreonam—Asthenia—Dexamethasone—ankylosing spondylitis	0.0023	0.0023	CcSEcCtD
Aztreonam—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.00228	0.00228	CcSEcCtD
Aztreonam—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00228	0.00228	CcSEcCtD
Aztreonam—Nausea—Prednisolone—ankylosing spondylitis	0.00228	0.00228	CcSEcCtD
Aztreonam—Pruritus—Dexamethasone—ankylosing spondylitis	0.00227	0.00227	CcSEcCtD
Aztreonam—Pruritus—Betamethasone—ankylosing spondylitis	0.00227	0.00227	CcSEcCtD
Aztreonam—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.00225	0.00225	CcSEcCtD
Aztreonam—Vomiting—Triamcinolone—ankylosing spondylitis	0.00224	0.00224	CcSEcCtD
Aztreonam—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00224	0.00224	CcSEcCtD
Aztreonam—Rash—Triamcinolone—ankylosing spondylitis	0.00223	0.00223	CcSEcCtD
Aztreonam—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00222	0.00222	CcSEcCtD
Aztreonam—Rash—Methylprednisolone—ankylosing spondylitis	0.00222	0.00222	CcSEcCtD
Aztreonam—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00222	0.00222	CcSEcCtD
Aztreonam—Urticaria—Prednisone—ankylosing spondylitis	0.00222	0.00222	CcSEcCtD
Aztreonam—Headache—Triamcinolone—ankylosing spondylitis	0.00221	0.00221	CcSEcCtD
Aztreonam—Headache—Methylprednisolone—ankylosing spondylitis	0.00221	0.00221	CcSEcCtD
Aztreonam—Body temperature increased—Prednisone—ankylosing spondylitis	0.00221	0.00221	CcSEcCtD
Aztreonam—Abdominal pain—Prednisone—ankylosing spondylitis	0.00221	0.00221	CcSEcCtD
Aztreonam—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00219	0.00219	CcSEcCtD
Aztreonam—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00219	0.00219	CcSEcCtD
Aztreonam—Hypotension—Methotrexate—ankylosing spondylitis	0.00218	0.00218	CcSEcCtD
Aztreonam—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.00212	0.00212	CcSEcCtD
Aztreonam—Dizziness—Dexamethasone—ankylosing spondylitis	0.00212	0.00212	CcSEcCtD
Aztreonam—Dizziness—Betamethasone—ankylosing spondylitis	0.00212	0.00212	CcSEcCtD
Aztreonam—Insomnia—Methotrexate—ankylosing spondylitis	0.00211	0.00211	CcSEcCtD
Aztreonam—Nausea—Triamcinolone—ankylosing spondylitis	0.0021	0.0021	CcSEcCtD
Aztreonam—Paraesthesia—Methotrexate—ankylosing spondylitis	0.00209	0.00209	CcSEcCtD
Aztreonam—Nausea—Methylprednisolone—ankylosing spondylitis	0.00209	0.00209	CcSEcCtD
Aztreonam—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00208	0.00208	CcSEcCtD
Aztreonam—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00206	0.00206	CcSEcCtD
Aztreonam—Vomiting—Dexamethasone—ankylosing spondylitis	0.00204	0.00204	CcSEcCtD
Aztreonam—Vomiting—Betamethasone—ankylosing spondylitis	0.00204	0.00204	CcSEcCtD
Aztreonam—Rash—Dexamethasone—ankylosing spondylitis	0.00202	0.00202	CcSEcCtD
Aztreonam—Rash—Betamethasone—ankylosing spondylitis	0.00202	0.00202	CcSEcCtD
Aztreonam—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00202	0.00202	CcSEcCtD
Aztreonam—Dermatitis—Betamethasone—ankylosing spondylitis	0.00202	0.00202	CcSEcCtD
Aztreonam—Headache—Dexamethasone—ankylosing spondylitis	0.00201	0.00201	CcSEcCtD
Aztreonam—Headache—Betamethasone—ankylosing spondylitis	0.00201	0.00201	CcSEcCtD
Aztreonam—Asthenia—Prednisone—ankylosing spondylitis	0.002	0.002	CcSEcCtD
Aztreonam—Pain—Methotrexate—ankylosing spondylitis	0.00199	0.00199	CcSEcCtD
Aztreonam—Pruritus—Prednisone—ankylosing spondylitis	0.00197	0.00197	CcSEcCtD
Aztreonam—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.00192	0.00192	CcSEcCtD
Aztreonam—Diarrhoea—Prednisone—ankylosing spondylitis	0.00191	0.00191	CcSEcCtD
Aztreonam—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.00191	0.00191	CcSEcCtD
Aztreonam—Nausea—Betamethasone—ankylosing spondylitis	0.0019	0.0019	CcSEcCtD
Aztreonam—Nausea—Dexamethasone—ankylosing spondylitis	0.0019	0.0019	CcSEcCtD
Aztreonam—Urticaria—Methotrexate—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Aztreonam—Dizziness—Prednisone—ankylosing spondylitis	0.00184	0.00184	CcSEcCtD
Aztreonam—Body temperature increased—Methotrexate—ankylosing spondylitis	0.00184	0.00184	CcSEcCtD
Aztreonam—Abdominal pain—Methotrexate—ankylosing spondylitis	0.00184	0.00184	CcSEcCtD
Aztreonam—Vomiting—Prednisone—ankylosing spondylitis	0.00177	0.00177	CcSEcCtD
Aztreonam—Rash—Prednisone—ankylosing spondylitis	0.00176	0.00176	CcSEcCtD
Aztreonam—Dermatitis—Prednisone—ankylosing spondylitis	0.00176	0.00176	CcSEcCtD
Aztreonam—Headache—Prednisone—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Aztreonam—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.00172	0.00172	CcSEcCtD
Aztreonam—Asthenia—Methotrexate—ankylosing spondylitis	0.00167	0.00167	CcSEcCtD
Aztreonam—Nausea—Prednisone—ankylosing spondylitis	0.00166	0.00166	CcSEcCtD
Aztreonam—Pruritus—Methotrexate—ankylosing spondylitis	0.00165	0.00165	CcSEcCtD
Aztreonam—Diarrhoea—Methotrexate—ankylosing spondylitis	0.0016	0.0016	CcSEcCtD
Aztreonam—Dizziness—Methotrexate—ankylosing spondylitis	0.00154	0.00154	CcSEcCtD
Aztreonam—Vomiting—Methotrexate—ankylosing spondylitis	0.00148	0.00148	CcSEcCtD
Aztreonam—Rash—Methotrexate—ankylosing spondylitis	0.00147	0.00147	CcSEcCtD
Aztreonam—Dermatitis—Methotrexate—ankylosing spondylitis	0.00147	0.00147	CcSEcCtD
Aztreonam—Headache—Methotrexate—ankylosing spondylitis	0.00146	0.00146	CcSEcCtD
Aztreonam—Nausea—Methotrexate—ankylosing spondylitis	0.00138	0.00138	CcSEcCtD
